Latest Immunosuppressants Stories
Potential U.S. Commercialization Targeted for 2014 CHICAGO, Jan.
HORSHOLM, Denmark, Jan.
HORSHOLM, Denmark, Dec. 30, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that it has submitted a New Drug Application (NDA) to the U.S.
ResearchMoz.us include new market research report " Global and China Monoclonal Antibody Industry Report, 2013 - 2017 " to its huge collection of research reports.
ChinaMarketResearchReports.com adds “Global and China Monoclonal Antibody Industry Report, 2013-2017” latest report to its store. Dallas, TX (PRWEB) December
- a meat pie that is usually eaten at Christmas in Quebec